Antioxidant systemic effect of short-term Cerebrolysin® administration

  • M. E. González
  • L. Francis
  • O. Castellano
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 53)


Levels of catalase (CAT) and Superoxide dismutase (SOD) activity were determinate in serum of intact rats (INT) and those with septohippocampal pathway lesion (SHPL), which recieved Cerebrolysin® (CRB) or saline solution (SAL) for a week. We found that Cerebrolysin® induces a decrease on the CAT and SOD levels. Decrease of CAT levels (19.1) in the group of SHPL-CRB was higher than the values obtained (57.3) in SHPL-SAL group. The lowest CAT levels were detected in the INT-CER group (16.7). The SOD levels obtained in SHPL-CER group (9.84) were also smaller than those obtained in the SHPL-SAL group (14.9) which showed the highest levels of SOD, while the INT animals showed the lowest levels (7.6). In addition, the SHPL animals mortality was of 18% for the CER group against 43% for SAL group. We suggest the Cerebrolysin® effect on CAT and SOD activity is related with a beneficial antioxidative role which may have potential application on brain injury.


Oxidative Imbalance Septal Cholinergic Neuron Hippocampal Pathway Reactive Oxigen Species Melanize Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121–126PubMedCrossRefGoogle Scholar
  2. Akai F, Hiruma S, Sato T, Iwamoto N, Ioku M, Hashimoto S (1992) Neurotrophic factor — like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histophaol 7: 213–221Google Scholar
  3. Benzi G, Moretti (1995) Age and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med 19: 77–101PubMedCrossRefGoogle Scholar
  4. Benzi G, Moretti A (1995) Are reactive oxygen species involve in Alzheimer disease? Neurobiol Aging 16: 661–674PubMedCrossRefGoogle Scholar
  5. Ceballos-Picot I, Trivier JM, Nicole A, Sinet PM, Thevenin M (1992) Age correlated modifications of Copper-Zinc Superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 38: 66–70PubMedGoogle Scholar
  6. Choi BH (1995) Oxidative stress and Alzheimer’s disease. Neurobiol Aging 16: 675–678PubMedCrossRefGoogle Scholar
  7. Colton C, Wilt S, Gilber D, Chernyshev O, Snell, Dubois-Dalq M (1996) Species differences in the generation of reactive oxigen species by microglia. Mol Chem Neuropathol 28: 15–20PubMedCrossRefGoogle Scholar
  8. De Haan JB, Cristiano F, Iannello RC, Kola I (1995) Cu/Zn Superoxide dismutase and gluthathione peroxidase during aging. Biochem Mol Biol Int 35: 1281–1297PubMedGoogle Scholar
  9. Durusoy M, Diril N, Bozcuk N (1995) Age-related activity of catalase in different genotypes of drosophila melanogaster. Exp Gerontol 30: 77–86PubMedCrossRefGoogle Scholar
  10. Ebewe pharmaceuticals (1992) Cerebrolysin for the modern effective theraphy of disturbed cerebral functions. Ebewe Arzneimittel Ges.m.b.H., A-4866 Unterach, Austria, p 84Google Scholar
  11. Marklund J (1992) Involvement of the Superoxide anion radical in autoxidation of pirogallol as a convenient assay for Superoxide dismutase. Eur J Biochem 47: 469–474CrossRefGoogle Scholar
  12. Matson MP, Furukawa K (1996) Progarmed cell life: anti-apoptotic signaling and therapeutic for neurodegenerative disorders. Restorat Neurol Neurosci 9: 191–205Google Scholar
  13. Mo JQ, Horn DG, Andersen JK (1995) Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech Ageing Dev 81: 73–82PubMedCrossRefGoogle Scholar
  14. Moreno S, Mugnaini E, Cerú P (1995) Inmunohistochemical localization of catalase in the central nervous system of the rat. J Histochem Cytochem 43: 1253–1267PubMedCrossRefGoogle Scholar
  15. Olanow CW (1992) An introduction to the free radical hypothesis in Parkinson’s disease. Ann Neurol 32: 2–9CrossRefGoogle Scholar
  16. Racagni G, Brunello N, Langer SZ (1994) Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction. In: Int Acad Biomed Drug Res, vol 7. Karger, Basel, p 327Google Scholar
  17. Singh A (1989) Chemical and biochemical aspects of activated oxygen: singlet oxygen, Superoxide anion, and related species. In: Handbook of free radicals and antioxidants in biomedicine, vol 1. Press, Iloride, pp 177–182Google Scholar
  18. Sugita Y, Kondo T, Kanazawa A, Itou T, Mixuno Y (1993) Protective effect of FPF 1070 (cerebrolysin) on delayed neuronal death in the gerbil: detection of hydroxyl radical with salisylic acid. No To Shinkei 45: 325–331PubMedGoogle Scholar
  19. Zhang P, Damier P, Hirsch EC, Agyd Y, Ceballos-Picot I, Sinet PM, Nicole A, Laurent M, Javoy-Agyd F (1993) Preferential expression of Superoxide dismutase messenger RNA in melanized neurons in human mesencephalom. Neuroscience 55: 167–175PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1998

Authors and Affiliations

  • M. E. González
    • 1
    • 4
  • L. Francis
    • 2
  • O. Castellano
    • 3
  1. 1.NeurobiochemistryInternational Center for Neurological RestorationPlaya Ciudad de la HabanaCuba
  2. 2.BiomodelsInternational Center for Neurological RestorationPlaya Ciudad de la HabanaCuba
  3. 3.Neuromorphology LaboratoryInternational Center for Neurological RestorationPlaya Ciudad de la HabanaCuba
  4. 4.Neurobiochemistry LaboratoryInternational center for Neurological RestorationCubanacán, Playa Ciudad de la HabanaCuba

Personalised recommendations